Anti-seizure medications for Lennox-Gastaut syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-seizure medications for Lennox-Gastaut syndrome

Published:2021-04-07 Issue:4 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Brigo Francesco¹,Jones Katherine²³,Eltze Christin⁴⁵,Matricardi Sara⁶

Affiliation:

1. Department of Neurology; Hospital of Merano (SABES-ASDAA); Merano-Meran Italy

2. Cochrane Neuromuscular; Queen Square Centre for Neuromuscular Diseases; London UK

3. Cochrane Pain, Palliative and Supportive Care; Oxford UK

4. University College London; London UK

5. Great Ormond Street Hospital for Children NHS Foundation Trust; London UK

6. Department of Child Neuropsychiatry; Children’s Hospital “G. Salesi”, Ospedali Riuniti Ancona; Ancona Italy

Publisher

Wiley

Subject

Pharmacology (medical)

Reference124 articles.

1. Evaluation of long-term safety, tolerability, and behavioral outcomes with adjunctive rufinamide in pediatric patients (≥1 to <4 years old) with Lennox-Gastaut syndrome: final results from randomized study 303;Arzimanoglou;European Journal of Paediatric Neurology,2019

2. Safety and cognitive development effects of rufinamide in paediatric patients with Lennox-Gastaut syndrome (LGS): study 303 final results;Arzimanoglou;Developmental Medicine and Child Neurology,2017

3. Safety and pharmacokinetic profile of rufinamide in pediatric patients aged less than 4 years with Lennox-Gastaut syndrome: an interim analysis from a multicenter, randomized, active-controlled, open-label study;Arzimanoglou;European Journal of Paediatric Neurology,2016

4. Novel seizure outcomes in patients with Lennox-Gastaut syndrome: post hoc analysis of seizure-free days in rufinamide Study 303;Auvin;Epilepsia Open,2019

5. Post hoc analysis of rufinamide study 303: seizure-free days in patients with Lennox-Gastaut Syndrome (LGS);Auvin;Neurology,2018

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-seizure Medications: Challenges and Opportunities;CNS & Neurological Disorders - Drug Targets;2024-09

2. A quantitative cross-sectional study of the burden of caring for patients with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex-associated epilepsy in Japan;Epilepsy & Behavior;2024-05

3. The latest advances in the pharmacological management of focal epilepsies in children: a narrative review;Expert Review of Neurotherapeutics;2024-03-05

4. Efficacy and safety of six new antiseizure medications for adjunctive treatment of focal epilepsy and epileptic syndrome: A systematic review and network meta-analysis;Epilepsy & Behavior;2024-03

5. Evaluating fenfluramine hydrochloride as an oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome;Expert Review of Neurotherapeutics;2024-02-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3